{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:50:41Z","timestamp":1786989041349,"version":"build-2736575974"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.eururo.2021.10.017","type":"journal-article","created":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T00:43:34Z","timestamp":1638578614000},"page":"396-406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Description of Surgical Technique and Oncologic and Functional Outcomes of the Precision Prostatectomy Procedure (IDEAL Stage 1\u20132b Study)"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5415-9901","authenticated-orcid":false,"given":"Akshay","family":"Sood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wooju","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Palma-Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firas","family":"Abdollah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Butaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Corsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hallie","family":"Wurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohrab","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Kachroo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oudai","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Gorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mani","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2021.10.017_b0005","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/jnci\/djp262","article-title":"Contemporary risk profile of prostate cancer in the United States","volume":"101","author":"Shao","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2021.10.017_b0010","doi-asserted-by":"crossref","first-page":"e955","DOI":"10.1016\/j.clgc.2017.04.014","article-title":"Variation in locoregional prostate cancer care and treatment trends at Commission on Cancer designated facilities: A National Cancer Data Base analysis 2004 to 2013","volume":"15","author":"Loppenberg","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.eururo.2021.10.017_b0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41391-019-0157-y","article-title":"Contemporary national trends in prostate cancer risk profile at diagnosis","volume":"23","author":"Fletcher","year":"2020","journal-title":"Prostate Cancer Prostat Dis"},{"key":"10.1016\/j.eururo.2021.10.017_b0020","doi-asserted-by":"crossref","first-page":"162","DOI":"10.6004\/jnccn.2010.0012","article-title":"NCCN clinical practice guidelines in oncology: prostate cancer","volume":"8","author":"Mohler","year":"2010","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.eururo.2021.10.017_b0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1113162","article-title":"Radical prostatectomy versus observation for localized prostate cancer","volume":"367","author":"Wilt","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2021.10.017_b0030","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa1615869","article-title":"Follow-up of prostatectomy versus observation for early prostate cancer","volume":"377","author":"Wilt","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2021.10.017_b0035","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1311593","article-title":"Radical prostatectomy or watchful waiting in early prostate cancer","volume":"370","author":"Bill-Axelson","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2021.10.017_b0040","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa1807801","article-title":"Radical prostatectomy or watchful waiting in prostate cancer \u2013 29-year follow-up","volume":"379","author":"Bill-Axelson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2021.10.017_b0045","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","article-title":"10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer","volume":"375","author":"Hamdy","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2021.10.017_b0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1012348","article-title":"Radiotherapy and short-term androgen deprivation for localized prostate cancer","volume":"365","author":"Jones","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2021.10.017_b0055","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.eururo.2013.03.005","article-title":"Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity","volume":"64","author":"Nepple","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0060","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.eururo.2014.06.025","article-title":"Oncologic outcomes at 10 years following robotic radical prostatectomy","volume":"67","author":"Diaz","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0065","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.juro.2010.11.046","article-title":"Cadaveric analysis of periprostatic nerve distribution: an anatomical basis for high anterior release during radical prostatectomy?","volume":"185","author":"Clarebrough","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0070","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1464-410X.2004.05106.x","article-title":"Anatomical studies of the neurovascular bundle and cavernosal nerves","volume":"94","author":"Costello","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2021.10.017_b0075","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.urology.2012.03.027","article-title":"Diffusion tensor magnetic resonance tractography of the prostate: feasibility for mapping periprostatic fibers","volume":"80","author":"Finley","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2021.10.017_b0080","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1056\/NEJMsa011788","article-title":"Variations in morbidity after radical prostatectomy","volume":"346","author":"Begg","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2021.10.017_b0085","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa1606221","article-title":"Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"375","author":"Donovan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2021.10.017_b0090","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1001\/jama.2017.1704","article-title":"Association between radiation therapy, surgery, or observation for localized prostate cancer and patient-reported outcomes after 3 years","volume":"317","author":"Barocas","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2021.10.017_b0095","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.eururo.2018.08.039","article-title":"Are we improving erectile function recovery after radical prostatectomy? Analysis of patients treated over the last decade","volume":"75","author":"Capogrosso","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0100","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1056\/NEJMoa074311","article-title":"Quality of life and satisfaction with outcome among prostate-cancer survivors","volume":"358","author":"Sanda","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2021.10.017_b0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/JU.0000000000000754","article-title":"Evaluating the trade-offs men with localized prostate cancer make between the risks and benefits of treatments: the COMPARE study","volume":"204","author":"Watson","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0110","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.eururo.2013.12.062","article-title":"Overdiagnosis and overtreatment of prostate cancer","volume":"65","author":"Loeb","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0115","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","article-title":"Long-term follow-up of a large active surveillance cohort of patients with prostate cancer","volume":"33","author":"Klotz","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2021.10.017_b0120","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1200\/JCO.2016.70.9527","article-title":"Active surveillance versus treatment of prostate cancer: should metastasis be the primary end point?","volume":"35","author":"D\u2019Amico","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2021.10.017_b0125","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.eururo.2019.10.030","article-title":"Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the ProtecT randomised controlled trial according to treatment received","volume":"77","author":"Neal","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0130","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.juro.2016.06.102","article-title":"Active surveillance for intermediate risk prostate cancer: survival outcomes in the Sunnybrook experience","volume":"196","author":"Musunuru","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0135","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/JU.0000000000000345","article-title":"Cost-effectiveness of active surveillance, radical prostatectomy and external beam radiotherapy for localized prostate cancer: an analysis of the ProtecT trial","volume":"202","author":"Sharma","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0140","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2021.10.017_b0145","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2010.12.013","article-title":"A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma","volume":"59","author":"Van Poppel","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0150","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMcibr0905562","article-title":"The index lesion and the origin of prostate cancer","volume":"361","author":"Ahmed","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2021.10.017_b0155","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6004\/jnccn.2020.0011","article-title":"Bladder cancer, version 3.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Flaig","year":"2020","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.eururo.2021.10.017_b0160","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nm.1944","article-title":"Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer","volume":"15","author":"Liu","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.eururo.2021.10.017_b0165","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1038\/s41467-020-18843-5","article-title":"Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy","volume":"11","author":"Woodcock","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.eururo.2021.10.017_b0170","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1470-2045(12)70121-3","article-title":"Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study","volume":"13","author":"Ahmed","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2021.10.017_b0175","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.juro.2017.03.137","article-title":"Partial gland treatment of prostate cancer using high-intensity focused ultrasound in the primary and salvage settings: a systematic review","volume":"198","author":"Golan","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0180","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.juro.2018.07.040","article-title":"Oncologic and functional outcomes of partial gland ablation with high intensity focused ultrasound for localized prostate cancer","volume":"201","author":"Bass","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0185","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/JU.0000000000000298","article-title":"Extensive histological sampling following focal therapy of clinically significant prostate cancer with high intensity focused ultrasound","volume":"202","author":"Mortezavi","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0190","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/JU.0000000000001126","article-title":"High intensity focused ultrasound hemigland ablation for prostate cancer: initial outcomes of a United States series","volume":"204","author":"Abreu","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0195","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/JU.0000000000001362","article-title":"Magnetic resonance imaging-guided transurethral ultrasound ablation of prostate cancer","volume":"205","author":"Klotz","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0200","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.eururo.2018.12.030","article-title":"Early-medium-term outcomes of primary focal cryotherapy to treat nonmetastatic clinically significant prostate cancer from a prospective multicentre registry","volume":"76","author":"Shah","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0205","article-title":"The precision prostatectomy: an IDEAL stage 0, 1 and 2a study","volume":"1","author":"Sood","year":"2019","journal-title":"BMJ Surg Interv Health Technol"},{"key":"10.1016\/j.eururo.2021.10.017_b0210","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.euf.2020.01.010","article-title":"The precision prostatectomy: \u201cwaiting for Godot\u201d","volume":"6","author":"Sood","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2021.10.017_b0215","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.21037\/tau-20-1476","article-title":"Subtotal surgical therapy for localized prostate cancer: a single-center precision prostatectomy experience in 25 patients, and SEER-registry data analysis","volume":"10","author":"Sood","year":"2021","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0220","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.eururo.2016.09.043","article-title":"Je le pansai, Dieu le guerit","volume":"72","author":"Sood","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0225","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0140-6736(09)61083-7","article-title":"Evaluation and stages of surgical innovations","volume":"374","author":"Barkun","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2021.10.017_b0230","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(09)61086-2","article-title":"Challenges in evaluating surgical innovation","volume":"374","author":"Ergina","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2021.10.017_b0235","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(09)61116-8","article-title":"No surgical innovation without evaluation: the IDEAL recommendations","volume":"374","author":"McCulloch","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2021.10.017_b0240","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.urology.2017.04.058","article-title":"Establishment of a Web-based system for collection of patient-reported outcomes after radical prostatectomy in a statewide quality improvement collaborative","volume":"107","author":"Lucas","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2021.10.017_b0245","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.eururo.2006.10.055","article-title":"Vattikuti Institute prostatectomy: contemporary technique and analysis of results","volume":"51","author":"Menon","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0250","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1089\/end.2012.0455","article-title":"Vattikuti Institute prostatectomy\u2014technique in 2012","volume":"26","author":"Ghani","year":"2012","journal-title":"J Endourol"},{"key":"10.1016\/j.eururo.2021.10.017_b0255","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MOU.0b013e328344e570","article-title":"Robotic radical prostatectomy: a critical analysis of surgical quality","volume":"21","author":"Sammon","year":"2011","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0260","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.juro.2013.05.032","article-title":"Adjuvant and salvage radiotherapy after prostatectomy: AUA\/ASTRO guideline","volume":"190","author":"Thompson","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0265","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2021.10.017_b0270","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/JU.0000000000000747","article-title":"Prostate specific antigen criteria to diagnose failure of cancer control following focal therapy of nonmetastatic prostate cancer using high intensity focused ultrasound","volume":"203","author":"Huber","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0275","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.eururo.2012.05.072","article-title":"Active surveillance for prostate cancer: a systematic review of the literature","volume":"62","author":"Dall\u2019Era","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0280","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/1097-0142(19921101)70:9<2313::AID-CNCR2820700917>3.0.CO;2-T","article-title":"Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors","volume":"70","author":"Villers","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2021.10.017_b0285","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.eururo.2018.01.001","article-title":"Focal therapy in primary localised prostate cancer: the European Association of Urology position in 2018","volume":"74","author":"van der Poel","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0290","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1148\/radiol.14140524","article-title":"How accurate is multiparametric MR imaging in evaluation of prostate cancer volume?","volume":"275","author":"Bratan","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.eururo.2021.10.017_b0295","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ng.3221","article-title":"Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue","volume":"47","author":"Cooper","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.eururo.2021.10.017_b0300","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.urology.2017.10.014","article-title":"The use of magnetic resonance imaging to predict oncological control among candidates for focal ablation of prostate cancer","volume":"112","author":"Kenigsberg","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2021.10.017_b0305","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1464-410X.1995.tb07224.x","article-title":"Erectile function following transurethral prostatectomy","volume":"75","author":"Hanbury","year":"1995","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0310","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1464-410X.2007.07169.x","article-title":"Total or partial prostate sparing cystectomy for invasive bladder cancer: long-term implications on erectile function","volume":"100","author":"Davila","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2021.10.017_b0315","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.eururo.2016.08.057","article-title":"Partial prostatectomy for anterior cancer: short-term oncologic and functional outcomes","volume":"72","author":"Villers","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.017_b0320","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.eururo.2018.06.006","article-title":"A multicentre study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate cancer","volume":"74","author":"Guillaumier","year":"2018","journal-title":"Eur Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283821021187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283821021187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:10:56Z","timestamp":1759583456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283821021187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0302283821021187"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2021.10.017","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Description of Surgical Technique and Oncologic and Functional Outcomes of the Precision Prostatectomy Procedure (IDEAL Stage 1\u20132b Study)","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2021.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}